HUP1100562A2 - Erlotinib salts - Google Patents

Erlotinib salts

Info

Publication number
HUP1100562A2
HUP1100562A2 HU1100562A HUP1100562A HUP1100562A2 HU P1100562 A2 HUP1100562 A2 HU P1100562A2 HU 1100562 A HU1100562 A HU 1100562A HU P1100562 A HUP1100562 A HU P1100562A HU P1100562 A2 HUP1100562 A2 HU P1100562A2
Authority
HU
Hungary
Prior art keywords
erlotinib
salts
erlotinib salts
Prior art date
Application number
HU1100562A
Other languages
Hungarian (hu)
Inventor
Ede Dr Marvanyos
Balazs Dr Volk
Laszlo Dr Pongo
Jozsef Dr Barkoczy
Andras Dr Dancso
Monika Mezoevari
Zoltan Varga
Original Assignee
Egis Gyogyszergyar Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyrt filed Critical Egis Gyogyszergyar Nyrt
Priority to HU1100562A priority Critical patent/HU230483B1/en
Priority to EA201490773A priority patent/EA201490773A1/en
Priority to PCT/HU2012/000102 priority patent/WO2013054147A2/en
Priority to BR112014008733A priority patent/BR112014008733A2/en
Priority to EP12826647.5A priority patent/EP2776406A2/en
Priority to CN201280058335.8A priority patent/CN103958483A/en
Publication of HUP1100562A2 publication Critical patent/HUP1100562A2/en
Publication of HU230483B1 publication Critical patent/HU230483B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
HU1100562A 2011-10-10 2011-10-10 Erlotinib salts HU230483B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU1100562A HU230483B1 (en) 2011-10-10 2011-10-10 Erlotinib salts
EA201490773A EA201490773A1 (en) 2011-10-10 2012-10-10 EXTRACTIONS OF EXPOSURE
PCT/HU2012/000102 WO2013054147A2 (en) 2011-10-10 2012-10-10 Erlotinib salts
BR112014008733A BR112014008733A2 (en) 2011-10-10 2012-10-10 erlotinib salts
EP12826647.5A EP2776406A2 (en) 2011-10-10 2012-10-10 Erlotinib salts
CN201280058335.8A CN103958483A (en) 2011-10-10 2012-10-10 Erlotinib salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100562A HU230483B1 (en) 2011-10-10 2011-10-10 Erlotinib salts

Publications (2)

Publication Number Publication Date
HUP1100562A2 true HUP1100562A2 (en) 2013-05-28
HU230483B1 HU230483B1 (en) 2016-07-28

Family

ID=89990469

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100562A HU230483B1 (en) 2011-10-10 2011-10-10 Erlotinib salts

Country Status (6)

Country Link
EP (1) EP2776406A2 (en)
CN (1) CN103958483A (en)
BR (1) BR112014008733A2 (en)
EA (1) EA201490773A1 (en)
HU (1) HU230483B1 (en)
WO (1) WO2013054147A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014118737A1 (en) * 2013-01-31 2014-08-07 Ranbaxy Laboratories Limited Erlotinib salts
CN104250230A (en) * 2014-09-05 2014-12-31 亿腾药业（泰州）有限公司 Erlotinib citrate, crystal form and preparation method of two

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69536015D1 (en) 1995-03-30 2009-12-10 Pfizer Prod Inc Quinazolinone derivatives
WO1999055683A1 (en) 1998-04-29 1999-11-04 Pfizer Products Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7960545B2 (en) * 2005-11-23 2011-06-14 Natco Pharma Limited Process for the prepartion of erlotinib
EP2139868B1 (en) 2007-04-04 2015-07-29 Cipla Limited Process for preparation of erlotinib and its pharmaceutically acceptable salts
CN102438995B (en) * 2009-03-26 2014-12-17 兰贝克赛实验室有限公司 Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
WO2011068403A2 (en) * 2009-12-02 2011-06-09 Ultimorphix Technologies B.V. Novel n-{3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamjne salts

Also Published As

Publication number Publication date
WO2013054147A2 (en) 2013-04-18
EA201490773A1 (en) 2014-10-30
CN103958483A (en) 2014-07-30
EP2776406A2 (en) 2014-09-17
BR112014008733A2 (en) 2017-04-25
WO2013054147A3 (en) 2013-06-13
HU230483B1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
HK1199840A1 (en) Noribogaine salt ansolvates
SG10201601802YA (en) Dispiropyrrolidine derivatives
ZA201401884B (en) New dihydroquinoline-2-one derivatives
IL247640B (en) Heteroarylpiperidine derivatives
GB2488877B (en) Insert
GB201304499D0 (en) Carcainium Salts
IL231950B (en) Aryl-quinoline derivatives
EP2721029A4 (en) Imidazopyridin-2-one derivatives
EP2785766A4 (en) Hydroxypolyamine salts
IL233001A0 (en) Novel iso-ergoline derivatives
GB201107301D0 (en) Alignment
SI2766342T1 (en) Phenyl-guanidine derivatives
HUP1100562A2 (en) Erlotinib salts
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
PL2760822T3 (en) Desfesoterodine salts
GB201106010D0 (en) Insert
GB201109024D0 (en) Can
GB201106819D0 (en) Novel salts
GB2496131B (en) Insert
ZA201209319B (en) Cyclopropyl-indole derivatives
GB201013511D0 (en) Salts
PT2791852T (en) Certisafe
AU340282S (en) Can
GB201109863D0 (en) Slot flexibility

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees